Live Breaking News & Updates on Coronavirus detection

Stay informed with the latest breaking news from Coronavirus detection on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Coronavirus detection and stay connected to the pulse of your community

Coronavirus | Seven-day average of daily vaccination improves

It stood at 25.98 lakh on June 4, against 18.1 lakh a month ago.

India , Tamil-nadu , Tripura , Ladakh , Jammu-and-kashmir , Karnataka , Chhattisgarh , Kerala , Nicobar-islands , Coronavirus , Lockdown

India has to buy time to ensure high coverage of COVID vaccination is achieved, says government

If the containment measures, COVID-19 appropriate behaviour or vaccination pace slackens, cases can rise again, it said.

India , Bharat-biotech , Coronavirus , Lockdown , Lockdown-extension , Single-day-spik-e , Covaxin , Covid-19-vaccine , Dexamethasone , Health-ministry , Icmr

Coronavirus | Decision on lockdown extension in Tamil Nadu to be announced on Saturday

Coronavirus | Decision on lockdown extension in Tamil Nadu to be announced on Saturday
Updated:
Updated:
Chief Secretary V. Irai Anbu, Director-General of Police J.K. Tripathy and senior officials participated.
Share Article
AAA
On Friday, Chief Minister M.K. Stalin chaired a meeting of officials to discuss the COVID-19 scenario and the lockdown restrictions across the State. | Photo Credit:
DIPR
Chief Secretary V. Irai Anbu, Director-General of Police J.K. Tripathy and senior officials participated.
The Tamil Nadu government would on Saturday announce whether the ongoing intense COVID-19 lockdown in the State would be extended beyond the morning of June 7 or not.

Tamil-nadu , India , V-irai-anbu , Policejk-tripathy , Coronavirus , Lockdown , Lockdown-extension , Single-day-spik-e , Covaxin , Covid-19-vaccine , Dexamethasone

Advocates raise concern over vaccine scarcity

Over 120 crore doses needed to cover 18-44 age group, they submit in SC

Meenakshi-arora , Jaideep-gupta , Supreme-court , Coronavirus , Lockdown , Lockdown-extension , Single-day-spik-e , Covaxin , Covid-19-vaccine , Dexamethasone , Health-ministry , Icmr

No decision yet on indemnity to vaccine makers: govt

Virus could come back in case people don’t act responsibly: Dr. Paul

India , Bharat , National-pharmaceutical-pricing-authority , Health-ministry , World-health-organisation , Bharat-biotech , Central-government , Coronavirus , Lockdown , Lockdown-extension , Single-day-spik-e

No decision yet on indemnity to COVID-19 vaccine makers: Government

Updated:
Virus could come back in case people don’t act responsibly: Dr. Paul
Share Article
AAA
Virus could come back in case people don’t act responsibly: Dr. Paul
The Union government was still in negotiation and no final decision had been taken on indemnity to either foreign or local COVID-19 vaccine manufacturers, NITI Aayog member (health) Dr. V.K. Paul said at a Health Ministry press conference on Friday.
India had overtaken the U.S. in providing at least one dose of vaccine. “As of Thursday night, India has administered 17.2 crore doses, while the U.S. has administered 16.9 crore doses,” he said.

India , Bharat , National-pharmaceutical-pricing-authority , Health-ministry , World-health-organisation , Bharat-biotech , Central-government , Coronavirus , Lockdown , Lockdown-extension , Single-day-spik-e

India welcomes lifting of U.S. curbs on export of vaccine ingredients

Vaccine gifts of 2-3 million doses may have little impact on India: officials

Japan , United-states , India , United-kingdom , Washington , Bhutan , American , Joseph-biden , Vinod-paul , Adar-poonawalla , Pfizer , Us-state-department-coordinator-for-global

Serum Institute gets DCGI's nod to manufacture Covid jab Sputnik V in India

SII plans to seek restricted emergency use permission of the vaccine in India.

Hadapsar , Maharashtra , India , Moscow , Moskva , Russia , Pune , Committee-on-genetic-manipulation , Gamaleya-research-institute-of-epidemiology , Serum-institute , Serum-institute-of-india

Serum Institute gets DCGI nod to manufacture Sputnik V COVID-19 vaccine in India

SII plans to seek restricted emergency use permission of the vaccine in India.
The DCGI has granted permission to the Serum Institute of India (SII) to manufacture the Sputnik COVID-19 vaccine in India for examination, test and analysis with certain conditions, official sources said on Friday.
The Pune-based firm has collaborated with Gamaleya Research Institute of Epidemiology and Microbiology, Moscow in Russia for developing Sputnik V at its licensed Hadapsar facility. “The DCGI has granted permission to the Serum Institute to manufacture the Sputnik COVID-19 vaccine in India for examination, test and analysis at its licensed Hadapsar facility with certain conditions,” an official source said.

Hadapsar , Maharashtra , India , Moscow , Moskva , Russia , Pune , Committee-on-genetic-manipulation , Gamaleya-research-institute-of-epidemiology , Serum-institute , Serum-institute-of-india

Coronavirus | India records over 1.13 lakh new cases, more than 2,500 deaths on June 4, 2021

Over 1.13 lakh new cases registered, accounting for one in three new infections.

India , Tamil-nadu , Ladakh , Jammu-and-kashmir , Manipur , Uttar-pradesh , Uttarakhand , Uttaranchal , Himachal-pradesh , Karnataka , Chhattisgarh , Kerala